Aveanna Healthcare vs Option Care Health
AVAH and OPCH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVAH and OPCH compare
Option Care Health is the larger company, worth 1.7 times as much as Aveanna Healthcare ($4.8B against $2.9B).
On earnings, Aveanna Healthcare is cheaper: it trades at 10.7× trailing earnings, against 23.9× for Option Care Health.
Aveanna Healthcare grew revenue faster over the last twelve months (19.5% versus 5.9% for Option Care Health).
Aveanna Healthcare keeps more of each dollar of sales as profit, with a net margin of 10.6% compared with 3.7% at Option Care Health.
Option Care Health scores higher on the StockData Score (14 against 11 for Aveanna Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVAH | OPCH |
|---|---|---|
| Size and price | ||
| Market cap | $2.9B | $4.8B |
| Share price | $13.16 | $31.83 |
| Change, 1 year | 33.5% | 11.0% |
| Change, 5 years | 57.4% | 14.0% |
| Beta (5Y) | 1.41 | 0.68 |
| Employees | 32K | 2,700 |
| StockData Score | ||
| Total score | 11 | 14 (better) |
| Valuation score | 3 | 3 |
| Growth score | 3 | 3 |
| Performance score | 4 (better) | 3 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 10.7× (better) | 23.9× |
| P/S | 1.1× | 0.8× (better) |
| P/B | 10.0× | 3.8× (better) |
| EV/EBITDA | 14.3× | 14.3× (better) |
| P/FCF | – | 15.7× |
| PEG | – | 1.57 |
| FCF yield | – | 6.4% |
| Fair value | $22.07 | $32.19 |
| Margin of safety | 40.4% (better) | 1.1% |
| Growth | ||
| Revenue growth (TTM) | 19.5% (better) | 5.9% |
| Revenue growth, 5Y average | 10.2% | 13.3% (better) |
| Net income growth (TTM) | 1381% (better) | −0.79% |
| EPS growth (TTM) | 1267% (better) | 6.4% |
| Profitability | ||
| Gross margin | 32.3% (better) | 19.1% |
| Operating margin | 10.5% (better) | 5.9% |
| Net margin | 10.6% (better) | 3.7% |
| FCF margin | – | 5.3% |
| Return on equity | 200% (better) | 16.0% |
| Return on invested capital | 20.6% (better) | 10.9% |
| Financial health | ||
| Debt / equity | 4.52 | 0.92 (better) |
| Net debt / EBITDA | 4.21 | 2.40 (better) |
| Interest coverage | 2.2× | 6.2× (better) |
| Current ratio | 1.16 | 1.47 (better) |
| Altman Z-score | 1.94 | 3.90 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 93.0% | 105% |
| Held by insiders | 16.9% | 1.6% |
| Insider net buying, 12 months | −$782M | $1.7M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 3.1% | 5.8% |
Go deeper
- AVAH stock overview
- AVAH income statement
- AVAH valuation and score
- OPCH stock overview
- OPCH income statement
- OPCH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.